The Charles Stark Draper Laboratory, Inc.
Draper is an independent nonprofit engineering innovation company with a legacy spanning over 90 years, dedicated to delivering transformative solutions for national security, prosperity, and global challenges. Renowned for its pioneering work in guidance, navigation, and control (GN&C) systems, Draper partners with government, industry, and academia to engineer advanced technologies in space, defense, biotechnology, and electronic systems. The company leverages multidisciplinary expertise, digital engineering, and a collaborative approach to provide field-ready prototypes, mission-critical systems, and innovative research. Draper’s mission is to ensure the nation's security and prosperity by delivering sustainable, cutting-edge solutions that address the toughest problems of today and tomorrow, while fostering an inclusive and diverse workforce. Draper also invests in the next generation of innovators through robust educational programs, including internships, co-ops, and the Draper Scholars Program, integrating academic research with real-world problem-solving.
Industries
N/A
Nr. of Employees
small (1-50)
The Charles Stark Draper Laboratory, Inc.
555 Technology Square, Cambridge, MA 02139
Patents
Highly deformable porous membrane culture system and actuation methods for studying the effects of biomechanical stretch on cultured tissue
US-12359155-B2
View Details
Highly deformable porous membrane culture system and actuation methods for studying the effects of biomechanical stretch on cultured tissue
US-12359155-B2
View DetailsProducts
Custom integrated circuit solutions
Mission-specific ASICs and SoCs designed for constrained environments, including analog, digital, mixed-signal, and radiation-mitigated variants, with verification and foundry integration.
Advanced packaging and microsystem assemblies
Packaged microsystems using multi-chip and heterogeneous integration tailored for high-reliability and harsh-environment applications, including onshore production capability.
High-throughput microphysiological system (MPS) platforms
Microfluidic culture plate platforms with multi-layer microchannel tissue units, independent apical/basal perfusion, integrated real-time sensing, and remote software control for preclinical screening and disease modeling.
Portable massively multiplexed nucleic-acid detection device
Field-directed detection systems combining automated sample prep, microfluidic disposable cartridges, high-efficiency mixing, and high-density capture arrays to screen large numbers of nucleic-acid targets rapidly.
Microfluidic blood oxygenator
Microfluidic blood oxygenation device that mimics physiological microcirculation using branched microchannel architectures to improve flow uniformity, reduce thrombosis and inflammation, and support low pediatric flow rates.
Bioprocessing modules and analytical monitoring systems
Modular bioprocessing hardware including acoustic cell separation units, continuous-flow electroporation modules, and portable DMS-based analytics for bioreactor monitoring and sterility detection.
Custom integrated circuit solutions
Mission-specific ASICs and SoCs designed for constrained environments, including analog, digital, mixed-signal, and radiation-mitigated variants, with verification and foundry integration.
Advanced packaging and microsystem assemblies
Packaged microsystems using multi-chip and heterogeneous integration tailored for high-reliability and harsh-environment applications, including onshore production capability.
High-throughput microphysiological system (MPS) platforms
Microfluidic culture plate platforms with multi-layer microchannel tissue units, independent apical/basal perfusion, integrated real-time sensing, and remote software control for preclinical screening and disease modeling.
Portable massively multiplexed nucleic-acid detection device
Field-directed detection systems combining automated sample prep, microfluidic disposable cartridges, high-efficiency mixing, and high-density capture arrays to screen large numbers of nucleic-acid targets rapidly.
Microfluidic blood oxygenator
Microfluidic blood oxygenation device that mimics physiological microcirculation using branched microchannel architectures to improve flow uniformity, reduce thrombosis and inflammation, and support low pediatric flow rates.
Bioprocessing modules and analytical monitoring systems
Modular bioprocessing hardware including acoustic cell separation units, continuous-flow electroporation modules, and portable DMS-based analytics for bioreactor monitoring and sterility detection.
Services
Program connecting emergent technology providers and capital partners with government stakeholders, providing technical vetting, lab access, and collaboration pathways to accelerate validation and government integration.
End-to-end support for microelectronic projects including ASIC design, verification, trusted-foundry integration, advanced packaging, and low-rate onshore production.
Engineering services for GN&C, alternative PNT, inertial navigation, vision-based navigation for EDL, autonomy/perception stacks, mission planning, and real-time simulation to support uncrewed and crewed systems.
Design and development of microphysiological systems, microfluidic devices, multi-organ models, integrated sensing, and preclinical assay workflows for drug screening, countermeasure evaluation, and biosurveillance.
Engineering of portable biodetection systems that combine automated sample preparation, microfluidic cartridges, multiplexed assays, and software control for field-deployable surveillance and rapid pathogen screening.
Development and deployment of modular hardware and software to automate key bioprocessing operations, increase throughput, and reduce manual labor in cell therapy and biologics production.
Program connecting emergent technology providers and capital partners with government stakeholders, providing technical vetting, lab access, and collaboration pathways to accelerate validation and government integration.
End-to-end support for microelectronic projects including ASIC design, verification, trusted-foundry integration, advanced packaging, and low-rate onshore production.
Engineering services for GN&C, alternative PNT, inertial navigation, vision-based navigation for EDL, autonomy/perception stacks, mission planning, and real-time simulation to support uncrewed and crewed systems.
Design and development of microphysiological systems, microfluidic devices, multi-organ models, integrated sensing, and preclinical assay workflows for drug screening, countermeasure evaluation, and biosurveillance.
Engineering of portable biodetection systems that combine automated sample preparation, microfluidic cartridges, multiplexed assays, and software control for field-deployable surveillance and rapid pathogen screening.
Development and deployment of modular hardware and software to automate key bioprocessing operations, increase throughput, and reduce manual labor in cell therapy and biologics production.
Expertise Areas
- Microelectronics and ASIC development
- Advanced packaging and heterogeneous integration
- Guidance, navigation, and control (GN&C) for space, hypersonic, and tactical systems
- Vision-based navigation and alternative PNT (celestial, signals-of-opportunity)
Key Technologies
- Application-specific integrated circuits (ASICs)
- Radiation-hardened electronics
- Three-dimensional heterogeneous integration (3DHI)
- Inertial measurement units (IMUs) and precision timing sensors
News & Updates
Draper Museum opens a new exhibit highlighting innovations in biomedical engineering, showcasing the company's legacy in national security and space exploration.
Draper joins the Intel Foundry Chiplet Alliance to support the development of interoperable and secure chiplet solutions.
Draper successfully completes pre-production testing of its celestial navigation system for aircraft, advancing navigation technology.
Kevin Duda of Draper joins a National Academies panel supporting the committee prioritizing key non-polar destinations across the Moon with human explorers.
Draper employees and a team are nominated for the RNASA Stellar Awards, recognizing excellence in aerospace achievement.
Draper supports the FDA's initiative to reduce reliance on animal testing, aligning with advancements in biomedical technology.
Draper Museum opens a new exhibit highlighting innovations in biomedical engineering, showcasing the company's legacy in national security and space exploration.
Draper joins the Intel Foundry Chiplet Alliance to support the development of interoperable and secure chiplet solutions.
Draper successfully completes pre-production testing of its celestial navigation system for aircraft, advancing navigation technology.
Kevin Duda of Draper joins a National Academies panel supporting the committee prioritizing key non-polar destinations across the Moon with human explorers.
Draper employees and a team are nominated for the RNASA Stellar Awards, recognizing excellence in aerospace achievement.
Draper supports the FDA's initiative to reduce reliance on animal testing, aligning with advancements in biomedical technology.